logo
Frito-Lay Tostitos chip recall upgraded to highest risk level — consumption ‘could cause death'

Frito-Lay Tostitos chip recall upgraded to highest risk level — consumption ‘could cause death'

Yahoo10-04-2025

Put the chip down!
The Food and Drug Administration increased the recall of one of Frito-Lay's most popular chips, noting they 'could cause death,' WKRC reported.
Tostitos Cantina Traditional Yellow Corn Tortilla Chips were recalled March 26 after Frito-Lay voluntarily recalled a batch of products.
A limited number of 13 oz. bags could include nacho cheese tortilla chips, meaning they may contain milk.
This could pose a 'risk of a serious or life-threatening allergic reaction' for those with an allergy or sensitivity to dairy.
According to WKRC, the recall has now been upgraded to Class I — the highest risk level.
This means 'there is a reasonable probability' that eating the chips could 'cause serious adverse health consequences or death' for some consumers.
Frito-Lay told The Post in a statement: 'Less than 1,300 bags of impacted products were for sale in stores in 13 states… and across digital channels since March 7… Unless a consumer has a dairy allergy or sensitivity to milk, this product is safe to consume. '
While the FDA has just classified this recall, the information for consumers has not changed since Frito-Lay first announced the recall late last month.
Frito-Lay believes that products currently on store shelves are not impacted. The company says it's likely that impacted products have already been sold or removed from store shelves.
Milk is one of the FDA's eight 'major food allergens' and can trigger serious allergic reactions in sensitive individuals, including hives, cramps, dizziness, swollen vocal cords and even unconsciousness.
The bags of mislabeled chips were distributed to a mix of retailers, including grocery, convenience and drug stores, as well as e-commerce distributors in Alabama, Florida, Georgia, Illinois, Indiana, Kentucky, Mississippi, North Carolina, Ohio, South Carolina, Tennessee, Virginia and West Virginia.
Frito-Lay Tostitos chip recall upgraded to highest risk level — consumption 'could cause death'
212,000 pounds of liquid eggs recalled over concerns toxic cleaning solution contaminated batch
14 tons of beef sticks recalled after 'pieces of metal' found in snack
Lean Cuisine, Stouffer's frozen food meals recalled over 'wood-like material'
Trader Joe's recalls frozen fruit product over 'foreign material' concerns: 'Please discard'
The affected chips can be identified by a manufacturing code of in which 'XX' is any number from 30 to 55): 471106504, 18 13:XX or 471106505, 85 13:XX or 471106506, 85:13 XX or 471106507, 85 13:XX
No allergic reactions or serious side effects related to this product have been reported to date.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ProZenith Launches Natural Supplement Formulated for Weight Management Support
ProZenith Launches Natural Supplement Formulated for Weight Management Support

Business Upturn

time22 minutes ago

  • Business Upturn

ProZenith Launches Natural Supplement Formulated for Weight Management Support

By GlobeNewswire Published on June 7, 2025, 06:50 IST Aurora, June 06, 2025 (GLOBE NEWSWIRE) — ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available through official online channels. ProZenith is intended for individuals pursuing support for general weight management and overall well-being. Its formulation includes select ingredients chosen to align with healthy routines and support individuals seeking help managing non-hunger-related snacking behaviors. Each purchase of ProZenith is covered by a 60-day refund policy, reflecting the company's customer-first return assurance framework. All ProZenith supplements are manufactured without genetically modified ingredients and adhere to U.S. quality standards. Production takes place in an FDA-registered facility that complies with current Good Manufacturing Practices (cGMP). ProZenith is currently available through the company's official online platform at with multiple purchase options provided for convenience. About ProZenith ProZenith develops nutritional supplements designed to support individuals on their wellness journeys. The company emphasizes high-quality manufacturing, transparency, and customer satisfaction as it continues to expand its product offerings for health-conscious consumers. For customer support inquiries, contact: [email protected] Disclaimer: This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Media Contact: Company: ProZenith ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 19655 E 35th Dr #100, Aurora, CO 80011 Email: [email protected] [email protected] Order Phone Support: (925) 217-7353 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results

Yahoo

timean hour ago

  • Yahoo

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results

On Thursday, Ascendiant analyst Edward Woo raised the price target on RenovoRx Inc. (NASDAQ:RNXT) to $11.50 from $11, while maintaining a Buy rating on the shares. This adjustment follows the company's strong revenue growth reported in its Q1 2025 results. Woo indicated that the commercialization of RenovoCath and anticipated positive clinical data in Q3 will serve as strong catalysts for the stock. A clinical researcher in a lab examining a new biopharmaceutical product. The Q1 result includes ~$200K in revenue from commercial sales of RenovoCath alone. RenovoCath is an FDA-cleared and dual-balloon catheter device for the targeted isolation of blood flow and delivery of fluids. R&D expenses increased to $1.7 million, up from $1.3 million in Q1 2024, which was driven by higher employee compensation and manufacturing costs during the quarter. The company's Phase 3 TIGeR-PaC clinical trial showed promising results, with patients experiencing a median overall survival of 16 months using their targeted approach compared to 10 months with standard chemotherapy. There was also a 65% reduction in adverse events like nausea and fatigue. This trial is evaluating the company's proprietary TAMP therapy platform for the treatment of Locally Advanced Pancreatic Cancer. RenovoRx Inc. (NASDAQ:RNXT) is a clinical-stage biopharmaceutical company that develops targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. While we acknowledge the potential of RNXT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

ProZenith Launches Natural Supplement Formulated for Weight Management Support
ProZenith Launches Natural Supplement Formulated for Weight Management Support

Yahoo

time5 hours ago

  • Yahoo

ProZenith Launches Natural Supplement Formulated for Weight Management Support

U.S.-Made Product Supports General Wellness Goals with a 60-Day Refund Policy Aurora, June 06, 2025 (GLOBE NEWSWIRE) -- ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available through official online channels. ProZenith is intended for individuals pursuing support for general weight management and overall well-being. Its formulation includes select ingredients chosen to align with healthy routines and support individuals seeking help managing non-hunger-related snacking behaviors. Each purchase of ProZenith is covered by a 60-day refund policy, reflecting the company's customer-first return assurance framework. All ProZenith supplements are manufactured without genetically modified ingredients and adhere to U.S. quality standards. Production takes place in an FDA-registered facility that complies with current Good Manufacturing Practices (cGMP). ProZenith is currently available through the company's official online platform at with multiple purchase options provided for convenience. About ProZenith ProZenith develops nutritional supplements designed to support individuals on their wellness journeys. The company emphasizes high-quality manufacturing, transparency, and customer satisfaction as it continues to expand its product offerings for health-conscious consumers. For customer support inquiries, contact:support@ Disclaimer:This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Media Contact: Company: ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 Email: support@ Order Phone Support: (925) 217-7353 CONTACT: Company: ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 Email: support@ Order Phone Support: (925) 217-7353Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store